Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated NSCLC.
Wang XS, Bai YF, Verma V, Yu RL, Tian W, Ao R, Deng Y, Xia JL, Zhu XQ, Liu H, Pan HX, Yang L, He YK, Bai HS, Luo X, Guo Y, Zhou MX, Sun YM, Zhang ZC, Li SM, Cheng X, Tan BX, Han LF, Liu YY, Zhang K, Zeng FX, Jia L, Hao XB, Wang YY, Feng G, Xie K, Lu Y, Zeng M. Wang XS, et al. Among authors: zeng fx. J Natl Cancer Inst. 2022 Jan 30:djac015. doi: 10.1093/jnci/djac015. Online ahead of print. J Natl Cancer Inst. 2022. PMID: 35094066
21 results